N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.07p
  • 52 Week Low: 0.40p
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 2,412,704
  • Market Cap: £3.75m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Nigel Theobald 12,389,919 £55,755
Luke Cairns 142,660 £642

Major Shareholders

Notifier** Holding Value*
TRACARTA LIMITED 150,000,000 £675,000
Northern Standard Limited 150,000,000 £675,000
Mathenz Marc Kay 74,000,000 £333,000
Patrick Byrne 43,162,500 £194,231
David Farrier 28,000,000 £126,000
Peel Hunt LLP 7,436,152 £33,463
MYLES MCNULTY 4,000,000 £18,000
Lynchwood Nominees Limited 690,800 £3,109
Barclays Stockbrokers Limited 447,800 £2,015
LR Nominees Limited 311,600 £1,402

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.07p
52 Week Low 0.40p
Volume 2,412,704
Shares Issued 832.28m
Market Cap £3.75m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.75% below the market average56.75% below the market average56.75% below the market average56.75% below the market average56.75% below the market average
72.09% below the sector average72.09% below the sector average72.09% below the sector average72.09% below the sector average72.09% below the sector average
Value
56.75% below the market average56.75% below the market average56.75% below the market average56.75% below the market average56.75% below the market average
72.09% below the sector average72.09% below the sector average72.09% below the sector average72.09% below the sector average72.09% below the sector average
Income Not Available
Growth
25.20% above the market average25.20% above the market average25.20% above the market average25.20% above the market average25.20% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:10 2,000,000 @ 0.46p
15:49 200 @ 0.50p
14:35 4,500 @ 0.41p
10:40 444 @ 0.50p
10:40 444 @ 0.40p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page